Literature DB >> 32890356

Tobacco Use Cessation in Three Patients Suffering from Psychotic Disorders: The Impact of the COVID-19 Pandemic.

Olivier Theuerkauff1, Catherine Hanak.   

Abstract

BACKGROUND: Tobacco use is one of the major causes of morbidity and mortality amoung patients suffering from psychotic disorders. The association between severe COVID-19 and tobacco use is still debated. The aim of this paper is to enhance the importance of providing up to date informations about nicotine and tobacco use in connection with the SARS-CoV-2-related conditions.
METHODS: We present 3 cases of sudden tobacco use cessation in 3 long-term heavy smokers receiving mental health care for chronic psychotic disorders. Fear of severe form of COVID-19 was their principal motivation. Nicotine replacement therapy and quitline counseling were provided and no major withdrawal symptoms were declared.
RESULTS: As mass media later wrongly presented tobacco use as a protective factor regarding COVID-19, all three patients resumed smoking. Rigorous counseling took advantage of psychotic symptoms to correct false informations and finally promote tobacco use cessation.
CONCLUSIONS: The COVID-19 pandemic might paradoxically represent a great motivational factor to quit smoking, espacially when considering patients suffering from severe mental health disorders. Beyond the terrible suffering it causes, we illustrate with a case serie that this opportunity must be exploited by mental health professionals to improve quality and life expectancy of their patients.

Entities:  

Mesh:

Year:  2020        PMID: 32890356

Source DB:  PubMed          Journal:  Psychiatr Danub        ISSN: 0353-5053            Impact factor:   1.063


  2 in total

1.  Associations between COVID-19 risk perceptions and smoking and quitting behavior among U.S. adults.

Authors:  Amy L Nyman; Claire A Spears; Victoria Churchill; Vuong V Do; Katherine C Henderson; Zachary B Massey; Reed M Reynolds; Jidong Huang
Journal:  Addict Behav Rep       Date:  2021-11-27

2.  A Clinical Study on the Brain Protection Effect of Propofol Anesthesia on Patients Undergoing Acute Craniocerebral Trauma Surgery Based on Blockchain.

Authors:  Hu Li; Jinfeng Li; Peng Su; JianJun Zhang; Ding Ma
Journal:  J Healthc Eng       Date:  2022-04-09       Impact factor: 3.822

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.